An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.
2 Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.
3 Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
4 Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, USA. Gowdyk14@ecu.edu.
1 Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.
2 Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.
3 Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
4 Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, USA. Gowdyk14@ecu.edu.
Laboratory rodent influenza infection models have been and continue to be a critical tool for understanding virus-host interactions during infection. The incidence of seasonal influenza infections coupled with the need for novel therapeutics and universal vaccines highlights the need to uncover novel mechanisms of pathogenesis and protection. Mouse models are extremely useful for the evaluation of influenza vaccines and provide an invaluable tool to probe the immune response. This chapter describes the technique of intranasal inoculation of male C57BL/6J mice with an H1N1 strain of influenza (A/Puerto Rico/8/1934) and methods for assessing the optimum dose for infection, viral titers in lung tissue, and severity of disease.
Picture illustrating the intranasal inoculation of virus to an anesthetized mouse.
Figure 1
Picture illustrating the intranasal inoculation of virus to an anesthetized mouse.
Figure 2
Percentage of weight loss of…
Figure 2
Percentage of weight loss of male C57BL/6 mice after saline or PR8 infection…
Figure 2
Percentage of weight loss of male C57BL/6 mice after saline or PR8 infection (either 1275 or 1700 FFU). Mice were euthanized if they lost more than 20% of their original body weight.
Figure 3
Lung histology of C57BL/6 mouse…
Figure 3
Lung histology of C57BL/6 mouse after saline or PR8 infection (day 3 or…
Figure 3
Lung histology of C57BL/6 mouse after saline or PR8 infection (day 3 or 7 post infection (p.i.)). H&E stain shown at 200×magnification.
Figure 4
Percentage of survival of male…
Figure 4
Percentage of survival of male C57BL/6 mice after saline or PR8 infection (either…
Figure 4
Percentage of survival of male C57BL/6 mice after saline or PR8 infection (either 1275, 1700, or 2000 FFU). Mice were euthanized if they lost more than 20% of their original body weight per institutional animal use guidelines.
Flannery B, Chung JR, Thaker SN, et al. (2017) Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. MMWR Morb Mortal Wkly Rep 66 (6):167–171. doi:10.15585/mmwr.mm6606a3
-
DOI
-
PMC
-
PubMed
Dugan VG, Blanton L, Elal AIA, et al. (2017) Update: Influenza Activity - United States, October 1-November 25, 2017. MMWR Morb Mortal Wkly Rep 66 (48):1318–1326. doi:10.15585/mmwr.mm6648a2
-
DOI
-
PMC
-
PubMed
Blanton L, Alabi N, Mustaquim D, et al. (2017) Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine. MMWR Morb Mortal Wkly Rep 66 (25):668–676. doi:10.15585/mmwr.mm6625a3
-
DOI
-
PMC
-
PubMed
Eilers R, Krabbe PF, van Essen TG, et al. (2013) Assessment of vaccine candidates for persons aged 50 and older: a review. BMC Geriatr 13:32. doi:10.1186/1471-2318-13-32
-
DOI
-
PMC
-
PubMed
Powell ND, Allen RG, Hufnagle AR, et al. (2011) Stressor-induced alterations of adaptive immunity to vaccination and viral pathogens. Immunol Allergy Clin North Am 31 (1):69–79. doi:10.1016/j.iac.2010.09.002
-
DOI
-
PMC
-
PubMed